Vytlačiť
1.
- Alirocumab reduces total non-fatal and fatal cardiovascular events - from the ODYSSEY OUTCOMES study / Murín J., Bulas J., Wawruch M.. Cardiology letters. - ISSN 1338-3655. - Vol. 28, no. 2-3 (2019), s. 94-98 : ilustr., grafy
- C 2635